feed

S&P 500—

NASDAQ—

DOW—

RUSSELL—

VIX—

US10Y—

DXY—

EUR/USD—

GBP/USD—

GOLD—

WTI—

BTC—

ETH—

AArphraTerminal

Arphra/Issuer/PFE

PFE

Pfizer Inc.

HealthcareDrug Manufacturers - GeneralUSUSD

$26.17

+0.93%Live · FMPMay 29, 2026

Market cap

$149.15B

52w range

23.06 – 28.75

P / E

—

EPS

—

Volume

21.04M

Revenue · FY

$62.58B

-1.65% YoY

Explain this page

Arphra AIPlain-English read on Pfizer Inc.’s valuation

Press releasestopic:all earnings guidance dividend buyback mna ipo split layoffs lawsuit regulation rating executive product macro

News sentiment · 90d

DB · scored

2026-05-01 bullish neutral bearish2026-05-13

Topic mix · 30d

DB · scored

dividend-0.132
regulation1.002
earnings0.251
mna1.001
product1.001

Social sentiment

DB · social

stocktwits

55%bullish

45% bearish·30 messages

Jun 01, 2026

News

DB · scored12

Can Pfizer Achieve High Single-Digit Revenue CAGR From 2029?+1.00
May 13, 2026Zacks Investment Researchmna product
European Commission Approves Pfizer's HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors+1.00
May 13, 2026Business Wireregulation
European Commission Approves Pfizer's HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors+1.00
May 13, 2026Business Wireregulation
Pfizer: Don't Pass On This Dirt-Cheap Buying Opportunity+0.25
May 12, 2026Seeking Alphaearnings dividend
Prediction: Pfizer Will Beat the Market Over the Next 5 Years+1.00
May 12, 2026Fool - Investing News
Rigel strikes licensing deal for Pfizer and Arvinas' breast cancer drug+1.00
May 12, 2026Reuters
Is Pfizer a Buy, Sell, or Hold in 2026?+0.50
May 12, 2026The Motley Fool
Pfizer's Net Income Drops in Q1. Is Its Dividend Still Safe?-0.50
May 12, 2026The Motley Fooldividend
Pfizer vs Moderna: Only One Pharma Giant Is a Winner In The Post-Covid Era
May 04, 202624/7 Wall Street
Pfizer Stock: Still Priced Like It's Dead Money+1.00
May 03, 2026The Motley Fool
US FDA approves Pfizer, Arvinas' breast cancer drug+1.00
May 01, 2026Reuters
Pfizer: Why You Should Double Down Into Q1+1.00
May 01, 2026Seeking Alphaearnings guidance